Business StandardCenter·
Sun Pharma's ILUMYA gets USFDA approval for psoriatic arthritis treatment
The US FDA approval expands ILUMYA's use beyond plaque psoriasis, adding a new treatment option for adults with active psoriatic arthritis
Read at Business Standard →




